Betamethasone Dipropionate Gel
Product Images NDC 51672-1309

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Betamethasone Dipropionate (NDC 51672-1309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Betamethasone 01)

Chemical structure of Betamethasone Dipropionate, depicting its steroid framework with multiple rings and functional groups including fluorine, hydroxyl, and acetate ester substituents.*

FDA Label Image

Principal Display Panel (15 g Tube Carton)

Packaging label for Betamethasone Dipropionate Gel (Augmented), 0.05%, topical gel, 15 g tube. Labels include the strength expressed as 0.05%, NDC 51672-1309, and instructions for use. The product is marked Rx only, for dermatological use only, and not for ophthalmic use. The labeler is Taro Pharmaceuticals, with manufacturing and distribution locations in Canada and the USA. The design features green and white panels with red accents and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.